State and local governments have just kicked off a major deadline in releasing opioid settlement funds a bit later. Following the combination $ 26 billion deal with opioid maker Johnson & Johnson and the “Big Three” distributors this summer, states were given the opportunity to join the deal, and individual counties and cities had until Jan. 2 to decide whether they would receive a portion of their state’s funds. . But the combination of closures linked to the pandemic and a lack of agreements between states and small municipalities slowed the process, and the deadline was extended by a few weeks. States we expect to see money this spring, provided that everything falls into place and the complicated task of deciding where the funding will actually go is resolved.
The deal, which was concluded in July 2021, will distribute a huge amount of money to states and local governments and could provide an opportunity to mitigate some of the damage drug companies have done since the 1990s. But the initial settlement was just the start of the process, and in the months to come, local governments will have to decide how to compensate for decades of damage and desperation. Recently, a report from the Centers for Disease Control and Prevention found that over one million Americans have died of overdose since 1999. Over 100,000 overdose deaths have been recorded in 2021. There really is no price for numbers like these.
But the money is certainly coming, and there will be a lot of it: in addition to what is often called the “global” agreement, thousands of individual trials against various pharmaceutical companies will continue to find a solution this year. On January 4, the Texas Attorney General announced that the state had reached a $ 64 million deal with Endo International, and in early December, Allergan agreed to pay New York State up to $ 200 million. Fearing a repetition of tobacco company regulations that have been spent, for example, about Colorado literacy programs and farm initiatives in Kentucky, attorneys general have placed limits on how the money can be spent. Johnson & Johnson Settlement Privileges “basic reduction strategies“Like naloxone and the treatment of incarcerated persons, although it also helps fund drug courts and alternative policing models.” Notably, neither diversion courts nor criminalization have had much of an impact on overdose deaths, when harm reduction has been shown time and time again to reliably keep people alive.